Discrepancy between Bioavailability and Hypotensive Effect of Oral and Sublingual Nifedipine

• Published in: American journal of therapeutics Vol. 2; no. 1; p. 3
• Main Authors: Palma-Aguirre, J. A., Montoya-Cabrera, M. A., du Souich, P., Hoyo-Vadillo, C., Flores-Murrieta, F. J., Castañeda-Hernández, G.
• Format: Journal Article
• Language: English
• Published: United States 01.01.1995
• ISSN: 1536-3686
• DOI: 10.1097/00045391-199501000-00002

Nifedipine, 10-mg capsules, were given orally and sublingually to six healthy volunteers according to a randomized crossover design. Nifedipine plasma levels, blood pressure, and heart rate were determined at several times after medication. C(max) was higher (134 plus minus 17 vs. 93 plus minus 2 ng ml(minus sign1), mean plus minus SD, P < 0.01) and occurred earlier (0.5 vs. 1 h) with oral than with sublingual nifedipine. However, there was no significant difference in AUC (268 plus minus 56 vs. 288 plus minus 35 ng h ml(minus sign1)) nor in t(1/2) (1.8 plus minus 0.2 vs. 1.9 plus minus 0.3 h), indicating that sublingual administration decreased the rate but not the extent of nifedipine absorption. Notwithstanding the difference in C(max), both routes yielded a similar reduction in diastolic blood pressure of 13 plus minus 1 mm Hg. Heart rate increase, which reflects the activation of homeostatic mechanisms, was greater with oral than with sublingual nifedipine, that is, 18 plus minus 1 vs. 13 plus minus 1 beats min(minus sign1), P < 0.01. It is concluded that slower absorption after sublingual administration increases nifedipine hypotensive efficiency by producing less counteracting homeostatic responses than the more rapidly absorbed oral nifedipine.